Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogenic MSC infusion in kidney transplantation recipients promotes within 4 hours distinct B cell and T cell phenotypes.

Frontiers in immunology - 1 Jan 2024

Hendriks Sanne H, Heidt Sebastiaan, Reinders Marlies E J, Koning Frits, van Kooten Cees

Abstract excerpt

Background: Infusion of mesenchymal stromal cells (MSCs) has been proposed as immune-modulatory therapy in solid organ transplantation. The use of allogenic MSCs could improve standardization and allow for direct availability of the product. Method: The nonrandomized phase Ib Neptune clinical trial provided safety and feasibility data on the use of allogenic bone-marrow-derived MSCs, infused in 10 patients at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to B-Lymphocytes
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Transplantation

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to T-Lymphocytes

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 39450174
DOI: 10.3389/fimmu.2024.1455300
PMCID: PMC11500071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogenic MSC infusion in kidney transplantation recipients promotes within 4 hours distinct B cell and T cell phenotypes.PMID 39450174Read ↗

Cell Therapy in Solid-Organ Transplant.Semantic proximity Read ↗

Mesenchymal Stromal Cells: A New Tool against Graft-versus-Host Disease?Semantic proximity Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Multiple infusions of ex vivo-expanded regulatory T cells promote CD163+ myeloid cells and kidney allograft survival in non-lymphodepleted non-human primatesSemantic proximity Read ↗

Optimizing stem cell infusion timing in the prevention of acute graft-versus-host diseaseSemantic proximity Read ↗

Evaluation of CD4+ CD25+/- CD39+ T-cell populations in peripheral blood of patients following kidney transplantation and during acute allograft rejection.Semantic proximity Read ↗

Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.Semantic proximity Read ↗

Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.Semantic proximity Read ↗

A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity.Semantic proximity Read ↗

The Implications of B-lineage Cells in Kidney Allografts.Semantic proximity Read ↗

Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.